Developed simvastatin chitosan nanoparticles co-crosslinked with tripolyphosphate and chondroitin sulfate for ASGPR-mediated targeted HCC delivery with enhanced oral bioavailability
Publication date: Available online 25 November 2020Source: Saudi Pharmaceutical JournalAuthor(s): Tarek M. Faris, Gamaleldin I. Harisa, Fars K. Alanazi, Ahmed M. Samy, Fahd A. Nasr
Source: Saudi Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | Middle East Health | Nanotechnology | Saudi Arabia Health | Simvastatin | Statin Therapy | Zocor